Steadymed Cash Flow - Quarterly (NASDAQ:STDY)

Add to My Stocks
$4.73 $0 (0%) STDY stock closing price Aug 30, 2018 (Closing)

The Steadymed cash flow statement helps investors understand how well the company is managing its cash flows. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Steadymed profits one has to check the income statement and for Steadymed debt one has to check the balance sheet. Steadymed had cash and cash equivalents of $32.45M at beginning of the quarter and $21.13M at quarter end of 2018 Q2. Steadymed cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. The cash from operating activities for Steadymed is $ 2018 Q2, which saw a decrease from previous quarter.

View and download details of Steadymed cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities1.85M--4.04M-3.78M-2.02M-2.56M-1.27M-1.09M-
Cash From (used in) Discontinued Operations----------
Other Adjustments Net7.91M4.58M4.21M2.52M16.41M12.96M-0.87M2.89M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-1.22M-0.48M-1.71M-0.99M-0.88M-0.71M-2.38M-1.15M-0.76M-0.63M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-------0.06M-0.06M-0.06M-
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--33.14M33.09M33.09M-19.58M19.58M--
Issuance (Repayment) of Debt Securities-------0.23M-0.23M-0.23M-0.14M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year32.45M23.21M31.85M6.16M2.07M7.74M----
Cash & Equivalents at Year End21.13M26.63M32.45M37.41M43.54M14.57M23.21M31.5M17.24M25.37M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Steadymed stock price history provides the price history of a stock, Steadymed stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Steadymed is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Steadymed stock price movement.
  • Cash Flow from operating activities: Steadymed reported a negative operating cash flow of $-10.22M till 2018 Q2 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-1.22M for STDY till last quarter 2018 Q2 report.
  • Cash flow from financing activities shows the flow of cash between Steadymed and its owners and creditors and was $- till 2018 Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Steadymed Cash Flow

FCF margin